Pimecrolimus cream 1% demonstrates better local tolerability than tacrolimus ointment 0.03% in pediatric patients with atopic dermatitis

被引：2

作者：

Kempers, S

Jarrat, M

Pariser, D

机构：

[1] Minnesota Clin Study Ctr, Fridley, MN USA

[2] DermRes Inc, Austin, TX USA

[3] Eastern Virginia Med Sch, Dept Dermatol, Norfolk, VA 23501 USA

[4] Virginia Clin Res Inc, Norfolk, VA USA

[5] Columbia Presbyterian Med Ctr, Dept Dermatol, New York, NY 10032 USA

来源：

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2004年 / 50卷 / 03期

关键词：

D O I：

10.1016/j.jaad.2003.10.018

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

P12

引用

页码：P3 / P3

页数：1

共 50 条

[1] Comparative pharmacokinetics of topical tacrolimus cream 0.03% with cream 0.01% and ointment 0.03% in adults and with ointment 0.03% in pediatric patients with atopic dermatitis
Jones, T
Apseloff, G
Carter, E
[J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2005, 52 (03) : P68 - P68
[2] Tacrolimus ointment versus pimecrolimus cream in patients with moderate atopic dermatitis
Breneman, D
Fleischer, AB
Antaya, R
Langley, RG
[J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2005, 52 (03) : P73 - P73
[3] A randomized investigator-blinded study comparing pimecrolimus cream 1% with tacrolimus ointment 0.03% in the treatment of pediatric patients with moderate atopic dermatitis
Kempers, S
Boguniewicz, M
Carter, E
Jarratt, M
Pariser, D
Stewart, D
Stiller, M
Tschen, E
Chon, K
Wisseh, S
Abrams, B
[J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2004, 51 (04) : 515 - 525
[4] Cost-effectiveness of tacrolimus ointment versus pimecrolimus cream in pediatric patients with atopic dermatitis
Taneja, Charu
Antaya, Richard
Berger, Ariel
Marshall, Thomas
[J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2008, 58 (02) : AB49 - AB49
[5] Tacrolimus ointment is more effective than pimecrolimus cream in adult patients with moderate to very severe atopic dermatitis
Fleischer, Alan B., Jr.
Abramovits, William
Breneman, Debra
Jaracz, Eileen
[J]. JOURNAL OF DERMATOLOGICAL TREATMENT, 2007, 18 (03) : 151 - 157
[6] Systemic exposure of pimecrolimus cream 1% and tacrolimus ointment 0.1% in adult patients with moderate to severe atopic dermatitis
Draelos, ZD
Hanifin, J
Chon, K
[J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2004, 50 (03) : P4 - P4
[7] Pimecrolimus Cream and Tacrolimus Ointment in the Treatment of Atopic Dermatitis: A Pilot Study on Patient Preference
Onumah, Neh
Kircik, Leon
[J]. JOURNAL OF DRUGS IN DERMATOLOGY, 2013, 12 (10) : 1145 - 1148
[8] Cost-effectiveness of Tacrolimus Ointment Versus Pimecrolimus Cream in Adults With Atopic Dermatitis
Taneja, Charu
Antaya, Richard J.
Berger, Ariel
Marshall, Thomas S.
Seifeldin, Raafat
Oster, Gerry
[J]. JOURNAL OF DRUGS IN DERMATOLOGY, 2010, 9 (04) : 372 - 376
[9] Systemic exposure, tolerability, and efficacy of pimecrolimus cream 1% in atopic dermatitis patients
Allen, BR
Lakhanpaul, M
Morris, A
Lateo, S
Davies, T
Scott, G
Cardno, M
Ebelin, ME
Burtin, P
Stephenson, TJ
[J]. ARCHIVES OF DISEASE IN CHILDHOOD, 2003, 88 (11) : 969 - 973
[10] Efficacy and local tolerability of pimecrolimus cream 1% in the treatment of atopic dermatitis in the face/neck region of pediatric subjects
Pariser, D
Paller, A
Langley, R
Paul, C
[J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2002, 119 (01) : 348 - 348

← 1 2 3 4 5 →